Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -11.279% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CC(C)Cn1c(=O)[nH]c(=O)c2c(C(F)(F)F)cc(-c3ccccc3)nc21
b.) CC1(C)CC2(CCO1)OC(=O)CC2C(=O)Nc1ccc(Br)cc1
Answer: b. CC1(C)CC2(CCO1)OC(=O)CC2C(=O)Nc1ccc(Br)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1(C)CC2(CCO1)OC(=O)CC2C(=O)Nc1ccc(Br)cc1
CC1(C)CC2(CCO1)OC(=O)CC2C(=O)Nc1ccc(Br)cc1
N-(4-bromophenyl)-7,7-dimethyl-2-oxo-1,8-dioxaspiro[4.5]decane-4-carboxamide